Angi director receives 13,500 RSUs; vesting schedule disclosed

Rhea-AI Filing Summary

Angi Inc. insider award reported: A director received 13,500 restricted stock units (RSUs) that each convert into one share of Class A common stock. The award vests in three installments—approximately 15%, 30% and 56%—on successive annual vesting dates beginning in 2027, and is scheduled to be fully vested by 2029, subject to continued service. The transaction was recorded as an acquisition and the reporting form was submitted by a single reporting person.

Positive

• Grant aligns director incentives with shareholders via time-based RSU vesting
• Clear vesting schedule disclosed: approximately 15%, 30%, and 56% across three vesting dates
• Grant is non-cash so no immediate cash outflow for the company

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Typical director equity award with standard multi-year vesting to align interests; no immediate dilution beyond the granted 13,500 shares.

The award appears structured to retain and align the director with shareholder interests through multi-year vesting. The staggered schedule accelerates vesting over three annual tranches, which encourages continued service. The grant size (13,500 RSUs) should be evaluated relative to Angi's outstanding share count to assess dilution, but the form itself shows no immediate transfer of shares—only contingent rights.

Securities Analyst

TL;DR: Non-cash compensation grant; modest in isolation but relevant for governance and compensation modeling.

From a capital-impact perspective, this is a non-derivative RSU award that will convert into common stock upon vesting. It does not affect cash flow now but will increase share count if fully issued. The vesting percentages (15%, 30%, 56%) and multi-year timeline are disclosed clearly, allowing modelers to schedule potential future dilution.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hicks Bowman Angela R.

(Last) (First) (Middle)

C/O ANGI INC.

3601 WALNUT STREET, SUITE 700

(Street)

DENVER CO 80205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Angi Inc. [ ANGI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/17/2025		A		13,500		(2)	(2)	Class A Common Stock, par value $0.001	13,500	$0	13,500	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.

2. Approximately fifteen percent (15%), thirty percent (30%) and fifty-six percent (56%) of the restricted stock units vest on March 1, 2027, March 1, 2028 and March 1, 2029, respectively, such that the award will be fully vested on March 1, 2029, subject to continued service.

Remarks:

	/s/ Shannon M. Shaw, as Attorney-in-Fact for Angela R. Hicks Bowman	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Angi insider Angela R. Hicks Bowman receive?

She received 13,500 restricted stock units (RSUs), each representing a contingent right to one share of Class A common stock.

When do the RSUs vest for ANGI director awards?

The RSUs vest in three tranches of approximately 15%, 30%, and 56%, with the award fully vesting by March 1, 2029, subject to continued service.

Does the Form 4 show an immediate stock sale or purchase for ANGI?

No. The Form 4 reports an acquisition of RSUs (a non-derivative contingent award), not an immediate transfer of shares for cash.

Will these RSUs cause dilution for ANGI shareholders?

If the RSUs vest and convert into shares, they will increase the share count by 13,500 shares, representing potential future dilution.

Was the Form 4 filed by multiple reporting persons?

No. The form indicates it was filed by one reporting person.